Shopping Cart 0
Cart Subtotal
USD 0

EndoStim Inc-Product Pipeline Analysis, 2017 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 750

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 1500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 2250

Details

Summary

EndoStim Inc (EndoStim) is a medical device company that offers therapeutic solutions. The company develops and commercializes a neurostimulation system for the treatment of severe gastroesophageal reflux disease. It concentrates on the treatment of gastroesophageal reflux disease through electrical stimulation. EndoStim also conducts clinical research for various drugs. The company conducts research on common symptoms and causes of gastroesophageal reflux disease. It markets its products in domestic and international healthcare markets through its network of distributors. The company has presence in Europe, Asia, and Latin America. EndoStim is headquartered in Dallas, Texas, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company EndoStim Inc

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

EndoStim Inc Company Overview 4

EndoStim Inc Company Snapshot 4

EndoStim Inc Pipeline Products and Ongoing Clinical Trials Overview 4

EndoStim Inc-Pipeline Analysis Overview 7

EndoStim Inc-Key Facts 7

EndoStim Inc-Major Products and Services 8

EndoStim Inc Pipeline Products by Development Stage 9

EndoStim Inc Ongoing Clinical Trials by Trial Status 11

EndoStim Inc Pipeline Products Overview 13

EndoStim LES Stimulation System 13

EndoStim LES Stimulation System Product Overview 13

EndoStim LES Stimulation System Clinical Trial 14

Implantable Device-Sexual Dysfunction 16

Implantable Device-Sexual Dysfunction Product Overview 16

Implantable Device-Urinary Incontinence 17

Implantable Device-Urinary Incontinence Product Overview 17

EndoStim Inc-Key Competitors 18

EndoStim Inc-Key Employees 19

EndoStim Inc-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Recent Developments 21

EndoStim Inc, Recent Developments 21

Apr 19, 2017: First patients at Vanderbilt University Medical Center implanted in EndoStim's LESS GERD clinical trial for gastroesophageal reflux disease (GERD) 21

Dec 20, 2016: First two patients at HonorHealth Research Institute implanted in EndoStim's LESS GERD clinical trial for gastroesophageal reflux disease (GERD) 21

Dec 01, 2016: First two patients at SurgOne Foregut Institute implanted in EndoStim's LESS GERD clinical trial for gastroesophageal reflux disease (GERD) 22

Nov 30, 2016: EndoStim Opens its New Corporate Headquarters in Dallas 23

Nov 03, 2016: First patient implanted in EndoStim's Lower Esophageal Sphincter Stimulation for GERD (LESS GERD) clinical trial 23

Oct 28, 2016: New data on EndoStim therapy for the treatment of gastro-esophageal reflux disease presented at United European Gastroenterology Week 2016 23

May 31, 2016: New data on EndoStim therapy for the treatment of gastro-esophageal reflux disease presented at Digestive Disease Week 2016 25

May 17, 2016: EndoStim Names Rohan Hoare, Ph.D., as New President and CEO 26

Dec 02, 2015: EndoStim's Neurostimulation Therapy for Gastroesophageal Reflux Disease Approved in Brazil 26

Oct 20, 2015: EndoStim Receives CE Mark Approval For Full Body MRI Of Patients With Its LES Stimulation System 27

Appendix 28

Methodology 28

About GlobalData 30

Contact Us 30

Disclaimer 30


List Of Figure

List of Figures

EndoStim Inc Pipeline Products by Equipment Type 5

EndoStim Inc Pipeline Products by Development Stage 9

EndoStim Inc Ongoing Clinical Trials by Trial Status 11


List Of Table

List of Tables

EndoStim Inc Pipeline Products and Ongoing Clinical Trials Overview 4

EndoStim Inc Pipeline Products by Equipment Type 5

EndoStim Inc Pipeline Products by Indication 6

EndoStim Inc Ongoing Clinical Trials by Trial Status 6

EndoStim Inc, Key Facts 7

EndoStim Inc, Major Products and Services 8

EndoStim Inc Number of Pipeline Products by Development Stage 9

EndoStim Inc Pipeline Products Summary by Development Stage 10

EndoStim Inc Ongoing Clinical Trials by Trial Status 11

EndoStim Inc Ongoing Clinical Trials Summary 12

EndoStim LES Stimulation System-Product Status 13

EndoStim LES Stimulation System-Product Description 13

EndoStim LES Stimulation System-A Multicenter, Randomized, Double-blind, Sham-controlled Clinical Investigation of the Endostim Lower Esophageal Sphincter (LES) Stimulation System for the Treatment of Gastroesophageal Reflux Disease (GERD) 14

EndoStim LES Stimulation System-An Investigation of Electrical Stimulation on Gastroesophageal Reflux Disease (GERD) in Patients after Sleeve Gastrectomy 14

EndoStim LES Stimulation System-An Investigation of the Effect of Long-term Electrical Stimulation on Lower Esophageal Sphincter (LES) Pressure and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease (GERD) 15

EndoStim LES Stimulation System-EndoStim Patient Registry-LES Stimulation System for the Treatment of GERD 15

EndoStim LES Stimulation System-Lost Patients-under-treated GERD Patients in Community Clinics in Germany 15

Implantable Device-Sexual Dysfunction-Product Status 16

Implantable Device-Sexual Dysfunction-Product Description 16

Implantable Device-Urinary Incontinence-Product Status 17

Implantable Device-Urinary Incontinence-Product Description 17

EndoStim Inc, Key Employees 19

EndoStim Inc, Other Locations 20

Glossary 29

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

EndoStim Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

Summary

EndoStim Inc (EndoStim) is a medical device company that offers therapeutic solutions. The company develops and commercializes a neurostimulation system for the treatment of severe gastroesophageal reflux disease. It concentrates on the treatment of gastroesophageal reflux disease through electrical stimulation. EndoStim also conducts clinical research for various drugs. The company conducts research on common symptoms and causes of gastroesophageal reflux disease. It markets its products in domestic and international healthcare markets through its network of distributors. The company has presence in Europe, Asia, and Latin America. EndoStim is headquartered in Dallas, Texas, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company EndoStim Inc

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

EndoStim Inc Company Overview 4

EndoStim Inc Company Snapshot 4

EndoStim Inc Pipeline Products and Ongoing Clinical Trials Overview 4

EndoStim Inc-Pipeline Analysis Overview 7

EndoStim Inc-Key Facts 7

EndoStim Inc-Major Products and Services 8

EndoStim Inc Pipeline Products by Development Stage 9

EndoStim Inc Ongoing Clinical Trials by Trial Status 11

EndoStim Inc Pipeline Products Overview 13

EndoStim LES Stimulation System 13

EndoStim LES Stimulation System Product Overview 13

EndoStim LES Stimulation System Clinical Trial 14

Implantable Device-Sexual Dysfunction 16

Implantable Device-Sexual Dysfunction Product Overview 16

Implantable Device-Urinary Incontinence 17

Implantable Device-Urinary Incontinence Product Overview 17

EndoStim Inc-Key Competitors 18

EndoStim Inc-Key Employees 19

EndoStim Inc-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Recent Developments 21

EndoStim Inc, Recent Developments 21

Apr 19, 2017: First patients at Vanderbilt University Medical Center implanted in EndoStim's LESS GERD clinical trial for gastroesophageal reflux disease (GERD) 21

Dec 20, 2016: First two patients at HonorHealth Research Institute implanted in EndoStim's LESS GERD clinical trial for gastroesophageal reflux disease (GERD) 21

Dec 01, 2016: First two patients at SurgOne Foregut Institute implanted in EndoStim's LESS GERD clinical trial for gastroesophageal reflux disease (GERD) 22

Nov 30, 2016: EndoStim Opens its New Corporate Headquarters in Dallas 23

Nov 03, 2016: First patient implanted in EndoStim's Lower Esophageal Sphincter Stimulation for GERD (LESS GERD) clinical trial 23

Oct 28, 2016: New data on EndoStim therapy for the treatment of gastro-esophageal reflux disease presented at United European Gastroenterology Week 2016 23

May 31, 2016: New data on EndoStim therapy for the treatment of gastro-esophageal reflux disease presented at Digestive Disease Week 2016 25

May 17, 2016: EndoStim Names Rohan Hoare, Ph.D., as New President and CEO 26

Dec 02, 2015: EndoStim's Neurostimulation Therapy for Gastroesophageal Reflux Disease Approved in Brazil 26

Oct 20, 2015: EndoStim Receives CE Mark Approval For Full Body MRI Of Patients With Its LES Stimulation System 27

Appendix 28

Methodology 28

About GlobalData 30

Contact Us 30

Disclaimer 30


List Of Figure

List of Figures

EndoStim Inc Pipeline Products by Equipment Type 5

EndoStim Inc Pipeline Products by Development Stage 9

EndoStim Inc Ongoing Clinical Trials by Trial Status 11


List Of Table

List of Tables

EndoStim Inc Pipeline Products and Ongoing Clinical Trials Overview 4

EndoStim Inc Pipeline Products by Equipment Type 5

EndoStim Inc Pipeline Products by Indication 6

EndoStim Inc Ongoing Clinical Trials by Trial Status 6

EndoStim Inc, Key Facts 7

EndoStim Inc, Major Products and Services 8

EndoStim Inc Number of Pipeline Products by Development Stage 9

EndoStim Inc Pipeline Products Summary by Development Stage 10

EndoStim Inc Ongoing Clinical Trials by Trial Status 11

EndoStim Inc Ongoing Clinical Trials Summary 12

EndoStim LES Stimulation System-Product Status 13

EndoStim LES Stimulation System-Product Description 13

EndoStim LES Stimulation System-A Multicenter, Randomized, Double-blind, Sham-controlled Clinical Investigation of the Endostim Lower Esophageal Sphincter (LES) Stimulation System for the Treatment of Gastroesophageal Reflux Disease (GERD) 14

EndoStim LES Stimulation System-An Investigation of Electrical Stimulation on Gastroesophageal Reflux Disease (GERD) in Patients after Sleeve Gastrectomy 14

EndoStim LES Stimulation System-An Investigation of the Effect of Long-term Electrical Stimulation on Lower Esophageal Sphincter (LES) Pressure and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease (GERD) 15

EndoStim LES Stimulation System-EndoStim Patient Registry-LES Stimulation System for the Treatment of GERD 15

EndoStim LES Stimulation System-Lost Patients-under-treated GERD Patients in Community Clinics in Germany 15

Implantable Device-Sexual Dysfunction-Product Status 16

Implantable Device-Sexual Dysfunction-Product Description 16

Implantable Device-Urinary Incontinence-Product Status 17

Implantable Device-Urinary Incontinence-Product Description 17

EndoStim Inc, Key Employees 19

EndoStim Inc, Other Locations 20

Glossary 29

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

EndoStim Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies